Dublin, Oct. 29, 2021 (GLOBE NEWSWIRE) -- The "The US Left Atrial Appendage Closure Device Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com's offering.
This report provides an in depth analysis of the US left atrial appendage closure device market by value, by product, by procedure, by end-user, etc. The report also provides a detailed analysis of the COVID-19 impact on the left atrial appendage closure device market.
Left atrial appendage closure is a nominal invading surgery that is done to decrease the chance of stroke that happens due to atrial fibrillation (also called as Afib or AF). Left atrial appendage closure is also called LAAC or LAA closure. Atrial fibrillation is a usual type of arrhythmia, a situation in which human heart beats out of rhythm. LAA closure equipment provides blood clot control as a substitute to blood thinners.
The US Left atrial appendage closure device market can be segmented on the basis of product, endoscopes, Epicardial left atrial appendage closure device and endocardial left atrial appendage closure device; on the basis of procedure, such as percutaneous and surgical and on the basis of end-users, such as hospitals, ambulatory surgery centres and others.
The US left atrial appendage closure device market has increased significantly during the years 2016-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The left atrial appendage closure device market is expected to increase due to aging population, growing gross national income, increasing prevalence of atrial fibrillation, increasing healthcare spending worldwide, growing urbanization and rising adoption of minimally invasive procedure. Yet, the market faces some challenges such as high cost of left atrial appendage closure procedure & equipment, unfavorable reimbursement policies in developing countries and high degree of competition.
The COVID-19 pandemic had a positive impact on the market because when restrictions were lifted people were getting their procedures done immediately as heart patients have lower survival chances if they catch coronavirus.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall left atrial appendage closure device market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The US left atrial appendage closure device market is fragmented with many major market players operating worldwide. The key players of the left atrial appendage closure device market are Johnson & Johnson, Abbott, Boston Scientific and Atricure are also profiled with their financial information and respective business strategies.
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 Heart: Overview
2.2 Functions of Heart
2.3 Structural Heart Problem: Overview
2.4 Types of Treatments Structural Heart Problems
2.5 Left Atrial Appendage Closure Device: Overview
2.6 Left Atrial Appendage Closure Device Segmentation: Overview
3. The US Market Analysis
3.1 The US Left Atrial Appendage Closure Device Market: An Analysis
3.1.1 The US Left Atrial Appendage Closure Device Market by Value
3.1.2 The US Left Atrial Appendage Closure Device Market by Product (Epicardial Left Atrial Appendage Closure Device and Endocardial Left Atrial Appendage Closure Device)
3.1.3 The US Left Atrial Appendage Closure Device Market by Procedure (Percutaneous and Surgical)
3.1.3 The US Left Atrial Appendage Closure Device Market by End-Users (Hospitals, Ambulatory Surgery Centres and Others)
3.2 The US Left Atrial Appendage Closure Device Market: Product Analysis
3.2.1 The US Epicardial Left Atrial Appendage Closure Device Market by Value
3.2.2 The US Endocardial Left Atrial Appendage Closure Device Market by Value
3.3 The US Left Atrial Appendage Closure Device Market: Procedure Analysis
3.3.1 The US Percutaneous Left Atrial Appendage Closure Device Market by Value
3.3.2 The US Surgical Left Atrial Appendage Closure Device Market by Value
3.4 The US Left Atrial Appendage Closure Device Market: End-User Analysis
3.4.1 The US Hospital Left Atrial Appendage Closure Device Market by Value
3.4.2 The US Ambulatory Surgery Centres Left Atrial Appendage Closure Device Market by Value
3.4.3 The US Other Left Atrial Appendage Closure Device Market by Value
4. Impact of COVID-19
4.1 COVID-19 Impact on Global Left Atrial Appendage Closure Device Market
4.2 Impact of COVID-19 on Health Services Spending
4.3 Leading Causes of Death in the US
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Aging Population
5.1.2 Growing Disposable Income
5.1.3 Increasing Prevalence of Atrial Fibrillation
5.1.4 Increasing Healthcare Spending Worldwide
5.1.5 Growing Urbanization
5.1.6 Rising Adoption of Minimally Invasive Procedure
5.2 Challenges
5.2.1 High Cost of Left Atrial Appendage Closure Procedure & Equipment
5.2.2 Unfavorable Reimbursement Policies in Developing Countries
5.2.3 High Degree of Competition
5.3 Market Trends
5.3.2 Partnerships among Major Players
5.3.2 Growing Healthcare Market in Emerging Economies
6. Competitive Landscape
6.1 The US Left Atrial Appendage Closure Device Market Players: Financial Comparison
6.2 The US Left Atrial Appendage Closure Device Market Players: R&D Comparison
7. Company Profiles
- Johnson & Johnson
- Abbott
- Boston Scientific
- Atricure
For more information about this report visit https://www.researchandmarkets.com/r/cn3bza
